Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease | Dementia and Cognitive Impairment | JAMA Neurology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.129.82. Please contact the publisher to request reinstatement.
1.
Petersen  RCSmith  GEWaring  SC  et al Mild cognitive impairment.  Arch Neurol.1999;56:303-308.Google Scholar
2.
Flicker  CFerris  SHReisberg  B Mild cognitive impairment in the elderly: predictors of dementia.  Neurology.1991;41:1006-1009.Google Scholar
3.
Petersen  RCSmith  GEIvnik  RJ  et al Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.  JAMA.1995;273:1274-1278.Google Scholar
4.
Tierney  MCSzalai  JPSnow  WG  et al Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study.  Neurology.1996;46:661-665.Google Scholar
5.
Devanand  DPFolz  MGorlyn  MMoeller  JRStern  Y Questionable dementia: clinical course and predictors of outcome.  J Am Geriatr Soc.1997;45:321-328.Google Scholar
6.
Bowen  JTeri  LKukull  W  et al Progression to dementia in patients with isolated memory loss.  Lancet.1997;349:763-765.Google Scholar
7.
O'Brien  JTBeats  BHill  K  et al Do subjective memory complaints precede dementia: a three-year follow-up of patients with supposed "benign senescent forgetfulness."  Int J Geriatr Psychiatry.1992;7:481-486.Google Scholar
8.
Daly  EZaitchik  DCopeland  M  et al Predicting conversion to Alzheimer disease using standardized clinical information.  Arch Neurol.2000;57:675-680.Google Scholar
9.
Small  GWLaRue  ALKomo  SKaplan  AMandelkern  MA Predictors of cognitive change in middle-aged and older adults with memory loss.  Am J Psychiatry.1995;152:1757-1764.Google Scholar
10.
Sherwin  BB Mild cognitive impairment: potential pharmacological treatment options.  J Am Geriatr Soc.2000;48:431-441.Google Scholar
11.
Morris  JC The Clinical Dementia Rating (CDR): current version and scoring rules.  Neurology.1993;43:2412-2414.Google Scholar
12.
Folstein  MFFolstein  SEMcHugh  PR Mini-Mental State: a practical method for grading the cognitive state of patients for the clinicians.  J Psychiatr Res.1975;12:189-198.Google Scholar
13.
Galasko  DKlauber  MRHofstetter  R The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease.  Arch Neurol.1990;47:49-52.Google Scholar
14.
Herlitz  ASmall  BJFratiglioni  L  et al Detection of mild dementia in community surveys.  Arch Neurol.1997;54:319-324.Google Scholar
15.
Koss  EPatterson  MBOwnby  RStuckey  JCWhitehouse  PJ Memory evaluation in Alzheimer's disease: caregivers' appraisals and objective testing.  Arch Neurol.1993;50:92-97.Google Scholar
16.
McGlone  JGupta  SHumphrey  D  et al Screening for early dementia using memory complaints from patients and relatives.  Arch Neurol.1990;47:1189-1193.Google Scholar
17.
Carr  DBGray  SBaty  JMorris  JC The value of informant vs. individual's complaints of memory impairment in early dementia.  Neurology.2000;55:1724-1726.Google Scholar
18.
Jorm  AF Methods of screening for dementia: a meta-analysis of studies comparing an informant questionnaire with a brief cognitive test.  Alzheimer Dis Assoc Disord.1997;11:158-162.Google Scholar
19.
Tierney  MCSzalai  JPSnow  WGFisher  RH The prediction of Alzheimer disease.  Arch Neurol.1996;53:423-427.Google Scholar
20.
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Third Edition.  Washington, DC: American Psychiatric Association;1980.
21.
Drachman  DAO'Donnell  BFLew  RASwearer  JM The prognosis in Alzheimer's disease: "how far" rather than "how fast" best predicts the course.  Arch Neurol.1990;47:851-856.Google Scholar
22.
Morris  JCEdland  SClark  C  et al The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part IV: rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease.  Neurology.1993;43:2457-2465.Google Scholar
23.
Howieson  DBDame  ACamicioli  R  et al Cognitive markers preceding Alzheimer's dementia in the healthy oldest old.  J Am Geriatr Soc.1997;45:584-589.Google Scholar
24.
Morris  JCMcKeel Jr  DWStorandt  M  et al Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging.  Neurology.1991;41:469-478.Google Scholar
25.
Morris  JCStorandt  MMcKeel  DW  et al Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease.  Neurology.1996;46:707-719.Google Scholar
26.
Price  JLMorris  JC Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.  Ann Neurol.1999;45:358-368.Google Scholar
27.
Berg  LHughes  CPDanziger  WLMartin  RLKnesevich  J Mild senile dementia of Alzheimer type (SDAT): research diagnostic criteria, recruitment, and description of a study population.  J Neurol Neurosurg Psychiatr.1982;45:962-968.Google Scholar
28.
Berg  LMcKeel Jr  DWMiller  JP  et al Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.  Arch Neurol.1998;55:326-335.Google Scholar
29.
Morris  JCMcKeel  DWFulling  KTorack  RMBerg  L Validation of clinical diagnostic criteria for Alzheimer's disease.  Ann Neurol.1988;24:17-22.Google Scholar
30.
McKhann  GDrachman  DFolstein  M  et al Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease.  Neurology.1984;34:939-944.Google Scholar
31.
Katzman  RBrown  TFuld  P  et al Validation of a short orientation-memory-concentration test of cognitive impairment.  Am J Psychiatry.1983;140:734-739.Google Scholar
32.
Hughes  CPBerg  LDanziger  WLCoben  LAMartin  RL A new clinical scale for the staging of dementia.  Br J Psychiatry.1982;140:566-572.Google Scholar
33.
Burke  WJMiller  JPRubin  EH  et al Reliability of the Washington University Clinical Dementia Rating.  Arch Neurol.1988;45:31-32.Google Scholar
34.
McCulla  MMCoats  MVan Fleet  N  et al Reliability of clinical nurse specialists in the staging of dementia.  Arch Neurol.1989;46:1210-1211.Google Scholar
35.
Morris  JCErnesto  CSchaefer  K  et al Clinical dementia rating (CDR) training and reliability protocol: the Alzheimer Disease Cooperative Study Unit experience.  Neurology.1997;48:1508-1510.Google Scholar
36.
Berg  LMiller  JPStorandt  M  et al Mild senile dementia of the Alzheimer type, 2: longitudinal assessment.  Ann Neurol.1988;23:477-484.Google Scholar
37.
Davis  PBWhite  HPrice  JLMcKeel  DWRobins  LN Retrospective postmortem dementia assessment: validation of a new clinical interview to assist neuropathologic study.  Arch Neurol.1991;48:613-617.Google Scholar
38.
Hixson  JEVernier  DT Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.  J Lipid Res.1990;31:545-548.Google Scholar
39.
Storandt  MHill  RD Very mild senile dementia of the Alzheimer type, II: psychometric test performance.  Arch Neurol.1989;46:383-386.Google Scholar
40.
Wechsler  DStone  CP Manual: Wechsler Memory Scale.  New York, NY: Psychological Corp; 1973.
41.
Benton  AL The Revised Visual Retention Test: Clinical and Experimental Applications.  New York, NY: Psychological Corp; 1963.
42.
Wechsler  D Manual: Wechsler Adult Intelligence Scale.  New York, NY: Psychological Corp;1955.>
43.
Goodglass  HKaplan  E The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia, Pa: Lea & Febiger; 1983.
44.
Thurstone  LLThurstone  LG Examiner Manual for the SRA Primary Mental Abilities Test.  Chicago, Ill: Science Research Associates;1949.
45.
Armitage  SG An analysis of certain psychological tests used in the evaluation of brain injury.  Psychol Monog.1946;60:1-48.Google Scholar
46.
Botwinick  JStorandt  M Speed functions, vocabulary ability, and age.  Percept Mot Skills.1973;36:1123-1128.Google Scholar
47.
Berg  LMcKeel Jr  DWMiller  JPBaty  JMorris  JC Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.  Arch Neurol.1993;50:349-358.Google Scholar
48.
McKeel Jr  DWBall  MJPrice  JL  et al Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results.  Alzheimer Dis Assoc Disord.1993;7:136-151.Google Scholar
49.
Khachaturian  ZS Diagnosis of Alzheimer's disease.  Arch Neurol.1985;42:1097-1105.Google Scholar
50.
Tinetti  MEWilliams  CSGill  TM Health, functional, and psychological outcomes among older persons with chronic dizziness.  J Am Geriatr Soc.2000;48:417-421.Google Scholar
51.
Morris  JCHeyman  AMohs  RC  et al The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I: clinical and neuropsychological assessment of Alzheimer's disease.  Neurology.1989;39:1159-1165.Google Scholar
52.
Petersen  RCSmith  GKokmen  EIvnik  RJTangalos  EG Memory function in normal aging.  Neurology.1992;42:396-401.Google Scholar
53.
Elias  MFBeiser  AWolf  PA  et al The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort.  Arch Neurol.2000;57:808-813.Google Scholar
54.
Robinson-Whelen  SStorandt  M Immediate and delayed prose recall among normal and demented adults.  Arch Neurol.1992;49:32-34.Google Scholar
55.
Crystal  HDickson  DFuld  P  et al Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease.  Neurology.1988;38:1682-1687.Google Scholar
56.
Rubin  EHStorandt  MMiller  JP  et al A prospective study of cognitive function and onset of dementia in cognitively healthy elders.  Arch Neurol.1998;55:395-401.Google Scholar
57.
Haan  MNShemanki  LJagust  WJManolio  TAKuller  L The role of APOE e4 in modulating effects of other risk factors for cognitive decline in elderly persons.  JAMA.1999;282:40-46.Google Scholar
58.
O'Connor  DWPollitt  PAHyde  JBMiller  NDFellowes  JL Clinical issues relating to the diagnosis of mild dementia in a British community survey.  Arch Neurol.1991;48:530-534.Google Scholar
59.
Graham  JERockwood  KBeattie  LB  et al Prevalence and severity of cognitive impairment with and without dementia in an elderly population.  Lancet.1997;349:1793-1796.Google Scholar
60.
Di Carlo  ABaldereschi  MAmaducci  L  et al Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability: the Italian longitudinal study on aging.  J Am Geriatr Soc.2000;48:775-782.Google Scholar
61.
Kawas  CHClark  CMFarlow  MR  et al Clinical trials in Alzheimer's disease: the debate on the use of placebo controls.  Alzheimer Dis Assoc Disord.1999;13:124-129.Google Scholar
Original Contribution
March 2001

Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease

Author Affiliations

From the Departments of Neurology (Drs Morris, Storandt, and Berg), Psychology (Dr Storandt), Pathology (Drs Morris and McKeel), Anatomy and Neurobiology (Dr Price), and Psychiatry (Dr Rubin), Division of Biostatistics (Mr Miller), and Alzheimer's Disease Research Center (Drs Morris, Storandt, McKeel, Price, Rubin, and Berg and Mr Miller), Washington University, St Louis, Mo.

Arch Neurol. 2001;58(3):397-405. doi:10.1001/archneur.58.3.397
Abstract

Background  Mild cognitive impairment (MCI) is considered to be a transitional stage between aging and Alzheimer disease (AD).

Objective  To determine whether MCI represents early-stage AD by examining its natural history and neuropathologic basis.

Design  A prospective clinical and psychometric study of community-living elderly volunteers, both nondemented and minimally cognitively impaired, followed up for up to 9.5 years. Neuropathologic examinations were performed on participants who had undergone autopsy.

Setting  An AD research center.

Participants  All participants enrolled between July 1990 and June 1997 with Clinical Dementia Rating (CDR) scores of 0 (cognitively healthy; n = 177; mean age, 78.9 years) or 0.5 (equivalent to MCI; n = 277; mean age, 76.9 years). Based on the degree of clinical confidence that MCI represented dementia of the Alzheimer type (DAT), 3 subgroups of individuals with CDR scores of 0.5 were identified: CDR 0.5/DAT, CDR 0.5/incipient DAT, and CDR 0.5/uncertain dementia.

Main Outcome Measure  Progression to the stage of CDR 1, which characterizes mild definite DAT.

Results  Survival analysis showed that 100% of CDR 0.5/DAT participants progressed to greater dementia severity over a 9.5-year period. At 5 years, rates of progression to a score of CDR 1 (or greater) for DAT were 60.5% (95% confidence interval [CI], 50.2%-70.8%) for the CDR 0.5/DAT group, 35.7% (95% CI, 21.0%-50.3%) for the CDR 0.5/incipient DAT group, 19.9% (95% CI, 8.0%-31.8%) for the CDR 0.5/uncertain dementia group, and 6.8% (95% CI, 2.2%-11.3%) for CDR 0/controls. Progression to greater dementia severity correlated with degree of cognitive impairment at baseline. Twenty-four of the 25 participants with scores of CDR 0.5 had a neuropathologic dementing disorder, which was AD in 21 (84%).

Conclusions  Individuals currently characterized as having MCI progress steadily to greater stages of dementia severity at rates dependent on the level of cognitive impairment at entry and they almost always have the neuropathologic features of AD. We conclude that MCI generally represents early-stage AD.

×